Amphiregulin Monoklonaler Antikörper

Amphiregulin Monoklonal Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

Hausschwein, human, Ratte

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1A1G9

Kat-Nr. : 66433-1-PBS

Synonyme

AREG, 1A1G9, AR, AREGB, Colorectum cell-derived growth factor



Geprüfte Anwendungen

Produktinformation

66433-1-PBS bindet in WB, IHC, Indirect ELISA Amphiregulin und zeigt Reaktivität mit Hausschwein, human, Ratten

Getestete Reaktivität Hausschwein, human, Ratte
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen Amphiregulin fusion protein Ag8907
Vollständiger Name amphiregulin
Berechnetes Molekulargewicht 252 aa, 28 kDa
Beobachtetes Molekulargewicht 50 kDa, 37 kDa
GenBank-ZugangsnummerBC009799
Gene symbol Amphiregulin/AREG
Gene ID (NCBI) 374
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Amphiregulin (AREG) is one of the ligands of the epidermal growth factor receptor (EGFR). AREG plays a central role in mammary gland development and branching morphogenesis in organs and is expressed both in physiological and in cancerous tissues. The AREG protein is synthesized as a 252-amino acid transmembrane precursor, pro-AREG. At the plasma membrane, pro-AREG is subjected to sequential proteolytic cleavages within its ectodomain and is then released as the soluble AREG protein. Depending on the cell type and microenvironment, AREG can be produced in multiple cellular and mature forms using alternative pro-AREG cleavage sites and glycosylation motifs. Post-translastional modfications of 50-kDa pro-AREG produces a major soluble 43-kDa form, 28-, 26-, 16-kDa membrane anchored forms, and soluble 21-, 19-, and 9-kDa forms (PMID: 9642297).